spacer
home > pmps > summer 2008 > free-flowing innovation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Free-Flowing Innovation

Interest in more advanced drug delivery systems has increased in line with the acceleration in the discovery and development of novel therapeutic macromolecules for targeted applications. Computational fluid dynamics (CFD) is a design tool that allows designers of these and other products to evaluate different designs rapidly and cost-effectively.

The use of CFD within the pharmaceutical industry has increased in recent years. Its application to the development of a new drug offers significant benefits in terms of yielding reduced costs, faster time to market, an improved understanding of existing or novel innovations, and the knowledge to make informed decisions to help guide and shape the direction of future research efforts.

These benefits are of particular significance in the search for an effective delivery system for a new drug – an issue that has become more pertinent in light of the recent moves away from needle- and syringe-based injection methods. Traditionally, animal experimentation has been used to evaluate drug delivery systems, but the results are not seen as sufficiently reliable when transposed to humans, whose respiratory physiology, for example, can differ greatly. This often leads to dramatically varying doses being realised from the same initial sample, making useful comparisons problematic.

In addition, an obligation exists under law to minimise experimentation on animals, placing restrictions on the level of testing that can be conducted. CFD can help overcome some of these issues, by allowing for the rapid and economic analysis of various drug delivery designs, using a three-dimensional model of human physiology.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stephen Grant of ANSYS is an engineer with a degree in Manufacturing Systems. He has spent much of his career working in large scale production and manufacture in the automotive industry. He moved into a commercial role as a Systems Integrator looking after a broad range of industries from automotive and defence through to pharmaceutical. Stephen is now responsible for ANSYS’s development and growth in the healthcare sector across the UK.
spacer
Stephen Grant
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement